{"transactions":[{"id":745794,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40386,"kind":"person","name":"Cannon Gillian","position":1,"cik":"0001833910","reported_name":"Cannon Gillian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-06-09T01:19:23.000Z","date":"2026-06-05","kind":"sale","planned":true,"acquired":false,"shares":1190,"price":53.14,"value":63236.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted by the reporting person on August 15, 2025, solely to satisfy income tax obligations related to the vesting of RSUs granted on June 5, 2025."}],"balance_after":1455,"source":{"system":"sec-edgar","filing":"0001193125-26-262671","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000119312526262671/ownership.xml","form_type":"4"}},{"id":750897,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40386,"kind":"person","name":"Cannon Gillian","position":1,"cik":"0001833910","reported_name":"Cannon Gillian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-06-04T01:03:40.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":1593,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each RSU represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each RSU represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders."}],"balance_after":1593,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":1593},"source":{"system":"sec-edgar","filing":"0001193125-26-256120","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000119312526256120/ownership.xml","form_type":"4"}},{"id":750896,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40386,"kind":"person","name":"Cannon Gillian","position":1,"cik":"0001833910","reported_name":"Cannon Gillian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2026-06-04T01:03:40.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":10507,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders."}],"balance_after":10507,"derivative":{"exercise_price":53.46,"expiration_date":"2036-06-02","underlying":"Common Shares","underlying_shares":10507},"source":{"system":"sec-edgar","filing":"0001193125-26-256120","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000119312526256120/ownership.xml","form_type":"4"}},{"id":750895,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40386,"kind":"person","name":"Cannon Gillian","position":1,"cik":"0001833910","reported_name":"Cannon Gillian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-06-04T01:03:40.000Z","date":"2026-06-01","kind":"exercise","planned":false,"acquired":false,"shares":2645,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents Common Shares earned and vested under a restricted share unit (\"RSU\") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents Common Shares earned and vested under a restricted share unit (\"RSU\") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents Common Shares earned and vested under a restricted share unit (\"RSU\") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders."}],"balance_after":0,"derivative":{"underlying":"Common Shares","underlying_shares":2645},"source":{"system":"sec-edgar","filing":"0001193125-26-256120","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000119312526256120/ownership.xml","form_type":"4"}},{"id":750894,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40386,"kind":"person","name":"Cannon Gillian","position":1,"cik":"0001833910","reported_name":"Cannon Gillian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-06-04T01:03:40.000Z","date":"2026-06-01","kind":"exercise","planned":false,"acquired":true,"shares":2645,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Common Shares earned and vested under a restricted share unit (\"RSU\") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Common Shares earned and vested under a restricted share unit (\"RSU\") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders."}],"balance_after":2645,"source":{"system":"sec-edgar","filing":"0001193125-26-256120","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000119312526256120/ownership.xml","form_type":"4"}},{"id":1043254,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":40386,"kind":"person","name":"Cannon Gillian","position":1,"cik":"0001833910","reported_name":"Cannon Gillian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-12T01:03:44.000Z","date":"2025-09-10","kind":"gift","planned":false,"acquired":false,"shares":7393,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a donation by the Reporting Person to Fidelity Charitable Giving Account."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-25-201561","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525201561/ownership.xml","form_type":"4"}},{"id":1046245,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":40386,"kind":"person","name":"Cannon Gillian","position":1,"cik":"0001833910","reported_name":"Cannon Gillian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2025-09-09T00:20:17.000Z","date":"2025-09-04","kind":"exercise","planned":false,"acquired":false,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully exercisable."}],"balance_after":49000,"derivative":{"exercise_price":22.99,"expiration_date":"2030-12-01","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001193125-25-198568","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525198568/ownership.xml","form_type":"4"}},{"id":1046244,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":40386,"kind":"person","name":"Cannon Gillian","position":1,"cik":"0001833910","reported_name":"Cannon Gillian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-09T00:20:17.000Z","date":"2025-09-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":3607,"price":70.13,"value":252958.91,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were withheld so the Reporting Person could satisfy the exercise price from a net (cashless) exercise of options."}],"balance_after":7393,"source":{"system":"sec-edgar","filing":"0001193125-25-198568","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525198568/ownership.xml","form_type":"4"}},{"id":1046243,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":40386,"kind":"person","name":"Cannon Gillian","position":1,"cik":"0001833910","reported_name":"Cannon Gillian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-09T00:20:17.000Z","date":"2025-09-04","kind":"exercise","planned":false,"acquired":true,"shares":11000,"price":22.99,"value":252890.0,"ownership":{"direct":true},"balance_after":11000,"source":{"system":"sec-edgar","filing":"0001193125-25-198568","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525198568/ownership.xml","form_type":"4"}},{"id":1114090,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":40386,"kind":"person","name":"Cannon Gillian","position":1,"cik":"0001833910","reported_name":"Cannon Gillian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2025-06-13T00:53:25.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable ratably in equal installments on each monthly anniversary of June 10, 2025 over a one-year period, subject to Reporting Person's continued service on each monthly vesting date."}],"balance_after":15000,"derivative":{"exercise_price":72.27,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000950170-25-085772","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025085772/ownership.xml","form_type":"4"}},{"id":1119179,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40386,"kind":"person","name":"Cannon Gillian","position":1,"cik":"0001833910","reported_name":"Cannon Gillian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2025-06-06T21:57:58.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":2645,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each restricted share unit represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 4, 2026 or (ii) the day before the date of the issuer's 2026 annual meeting of shareholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted share unit represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 4, 2026 or (ii) the day before the date of the issuer's 2026 annual meeting of shareholders."}],"balance_after":2645,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":2645},"source":{"system":"sec-edgar","filing":"0000950170-25-083318","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000095017025083318/ownership.xml","form_type":"4"}},{"id":1119178,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40386,"kind":"person","name":"Cannon Gillian","position":1,"cik":"0001833910","reported_name":"Cannon Gillian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2025-06-06T21:57:58.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":17012,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting 100% on the earlier of (i) June 4, 2026 or (ii) the day before the date of the issuer's 2026 annual meeting of shareholders."}],"balance_after":17012,"derivative":{"exercise_price":30.73,"expiration_date":"2035-06-04","underlying":"Common Shares","underlying_shares":17012},"source":{"system":"sec-edgar","filing":"0000950170-25-083318","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000095017025083318/ownership.xml","form_type":"4"}},{"id":1489460,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40386,"kind":"person","name":"Cannon Gillian","position":1,"cik":"0001833910","reported_name":"Cannon Gillian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-05T21:41:52.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":15542,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting 100% on the earlier of (i) June 4, 2025 or (ii) the day before the date of the issuer's 2025 annual meeting of shareholders."}],"balance_after":15542,"derivative":{"exercise_price":38.16,"expiration_date":"2034-06-04","underlying":"Common Shares","underlying_shares":15542},"source":{"system":"sec-edgar","filing":"0000950170-24-069463","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000095017024069463/ownership.xml","form_type":"4"}},{"id":1507599,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":40386,"kind":"person","name":"Cannon Gillian","position":1,"cik":"0001833910","reported_name":"Cannon Gillian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2024-05-21T22:25:15.000Z","date":"2024-05-17","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable ratably in equal installments on each monthly anniversary of May 17, 2024 over a one-year period."}],"balance_after":30000,"derivative":{"exercise_price":28.09,"expiration_date":"2034-05-16","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000950170-24-063156","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024063156/ownership.xml","form_type":"4"}},{"id":1810613,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40386,"kind":"person","name":"Cannon Gillian","position":1,"cik":"0001833910","reported_name":"Cannon Gillian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-10T22:56:05.000Z","date":"2023-08-10","kind":"grant","planned":false,"acquired":true,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the total shares subject to the Option shall vest on the first anniversary of August 8, 2023 (the \"Start Date\"), one-third on the second anniversary of the Start Date and the balance on the third anniversary of the Start Date."}],"balance_after":28000,"derivative":{"exercise_price":38.39,"expiration_date":"2033-08-09","underlying":"Common Shares","underlying_shares":28000},"source":{"system":"sec-edgar","filing":"0000950170-23-041528","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000095017023041528/ownership.xml","form_type":"4"}},{"id":1881511,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":40386,"kind":"person","name":"Cannon Gillian","position":1,"cik":"0001833910","reported_name":"Cannon Gillian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2023-05-23T21:00:28.000Z","date":"2023-05-19","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable ratably in equal installments on each monthly anniversary of May 19, 2023 over a one-year period."}],"balance_after":30000,"derivative":{"exercise_price":24.1,"expiration_date":"2033-05-18","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000899243-23-013737","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924323013737/doc4.xml","form_type":"4"}},{"id":2248082,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":40386,"kind":"person","name":"Cannon Gillian","position":1,"cik":"0001833910","reported_name":"Cannon Gillian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2022-06-02T21:00:53.000Z","date":"2022-05-31","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable ratably in equal installments on each monthly anniversary of May 31, 2022 over a one-year period."}],"balance_after":20000,"derivative":{"exercise_price":20.84,"expiration_date":"2032-05-30","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000899243-22-020702","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924322020702/doc4.xml","form_type":"4"}},{"id":2691831,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":40386,"kind":"person","name":"Cannon Gillian","position":1,"cik":"0001833910","reported_name":"Cannon Gillian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-28T21:05:55.000Z","date":"2021-05-26","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable ratably in equal installments on each monthly anniversary of May 26, 2021 over a one-year period."}],"balance_after":20000,"derivative":{"exercise_price":21.45,"expiration_date":"2031-05-25","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000899243-21-021130","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924321021130/doc4.xml","form_type":"4"}},{"id":2961441,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":40386,"kind":"person","name":"Cannon Gillian","position":1,"cik":"0001833910","reported_name":"Cannon Gillian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-03T00:26:27.000Z","date":"2020-12-01","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the stock option vest and become exercisable with respect to 25% of the shares on the first anniversary of the date of grant and, thereafter, at the rate of 2.08334% of the total number of shares per month, until fully vested and exercisable on the fourth anniversary of the date of grant, subject to the Reporting Person's continued service."}],"balance_after":60000,"derivative":{"exercise_price":22.99,"expiration_date":"2030-12-01","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0000899243-20-032579","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924320032579/doc4.xml","form_type":"4"}}]}